Here’s a simple, yet very emotional spot for the Québec Cystic Fibrosis Association.

Description:
A boy and a girl each blow on a dandelion to see their seeds fly in the air.

[SUPER]
La fibrose kystique est la maladie génétique mortelle la plus répendue chez les jeunes Canadiens.
On pense qu’au Canada, un nouveau-né sur 3600 est atteint de fibrose kystique.
50% des personnes atteintes sont des enfants.

the boy tries blowing on the dandelion again but starts coughing.
Donnez le souffle de vie.
Aidez les personnes atteintes à  réaliser leur voeu le plus cher.
Aidez-nous à vaincre la fibrose kystique.

www.aqfk.qc.ca

Cystic fibrosis is a fatal genetic disease most spread among young Canadians.
We believe that in Canada, a newborn in 3600 is suffering from cystic fibrosis.
50% of sufferers are children.
Give the breath of life.
Help people realize their fondest wish.
Help us fight cystic fibrosis.
www.aqfk.qc.ca

Brand name: Association québécoise de la fibrose kystique and Fondation canadienne de la fibrose kystique
Generic name/category: disease awareness, fund-raising
Country/Market: Canada, North America
Indication(s)/use: Cystic Fibrosis
Target: Consumers (DTC)
Medium: TV commercial
Size/duration: 42 seconds
Publication/Aired: 2009

This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.

Click here to see view the commercial.

This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.

Description: A man talks on-screen about the dangers of high cholesterol that may cause plaque buildup. He then invites viewers to visit Arterytour.com to get additional information via their interactive online tour. Arterytour.com is a comprehensive sales-pitch site for Crestor. Whats new about this site is that it uses a form of augmented reality to educate people about high cholesterol and plaque buildup.

Click here to visit the site.

To see all of the ads from this campaign, click here

Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Consumer (DTC)
Medium: TV commercial
Size/duration: 60 seconds
Publication: 2009

To see all Crestor ads, click here

From Wikipedia:
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Shionogi developed the product and the pharmaceutical company AstraZeneca markets it as Crestor.

Rosuvastatin is approved for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia).

As of 2004, rosuvastatin had been approved in 154 countries and launched in 56. Approval in the United States by the FDA came on August 12, 2003.

More on Wikipedia

Click here to see the details and full-size version of this ad on AdPharm

This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.

Description: People from different walks of life talk about cholesterol and how much they thought they knew about it and in reality they don’t. A spokesperson then comes in and talks about the risks associated with high cholesterol and its link with plaque buildup using animated visuals…

To see all of the ads from this campaign, click here

Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Consumer (DTC)
Medium: TV commercial
Size/duration: 60 seconds
Publication: 2009

To see all Crestor ads, click here

From Wikipedia:
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Shionogi developed the product and the pharmaceutical company AstraZeneca markets it as Crestor.

Rosuvastatin is approved for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia).

As of 2004, rosuvastatin had been approved in 154 countries and launched in 56. Approval in the United States by the FDA came on August 12, 2003.

More on Wikipedia

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click here to see the details and full-size versions of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Microsite

Have you heard of Pharmageddon 2012? If you follow the pharmaceutical industry on social media at all, it’s almost impossible not to. It’s on YouTube, Facebook, Flickr. It has it’s own blog on the Wordpress site, it’s listed on Technocrati, there’s an RSS feed and they’re also on Twitter.

Can we talk about an over-saturation of social media here? Maybe… but it’s certainly an interesting way of promoting the use of those new communications channels readily available to everyone.

Read the rest of this entry »

Hai education bus

HAI Watch News

HAI Watch health portal

Not on my watch is a disease awareness effort from Kimberly-Clark to educate both the healthcare community and general public on the risks of Health-Associated infection (HAI). The program includes a web portal, a tour bus which features a mini-classroom to give accredited CHE/CME formations regarding HAI on-site and a PR microsite supplying information to media outlets about the program.

The HAI Watch health portal is a resource to help keep health organizations aware of the importance of health-associated infection prevention. The site sections include:

• HAI issues (Ventilator-Associated Pneumonia (VAP) / Surgical Site Infections (SSI) / Cross Contamination)
• Tools (which is extensive with lists of guidelines and links to useful information)
• Clinical Education (which offers accredited CHE programs)
• News and events
• AI champions (with feature stories and case studies)
• Partners and organizations

Plus New HAI awareness tools are added on an ongoing basis.

haiwatchnews.com is a PR page set by Abraham & Harrison to inform medias about the problem and where to find multi-media materials to spread the word.

Also part of the program are two YouTube videos, the first one is about the program itself.

And the second YouTube video is about proper hand-washing to prevent infection and it’s produced by the CDC.

Agency: Abraham & Harrison

Brand name: HAI – Not on my watch
Generic name/category: public service and awareness
Company: Kimberly-Clark
Country/Market: USA, North America
Indication(s)/use: Health-Associated Infections
Target: Consumers (DTC) / Healthcare Professionals (HCP)
Tagline: Not on my watch
Medium: Internet
Size/duration: Web site / Portal / Social Media
Publication/Aired: 2009
Source: haiwatchnews.com/

More Social Media on AdPharm.net